Filing Details

Accession Number:
0001209191-23-057374
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-05 16:00:09
Reporting Period:
2023-12-01
Accepted Time:
2023-12-05 16:00:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1743881 Bridgebio Pharma Inc. BBIO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1337801 W. Randal Scott C/O Bridgebio Pharma, Inc.
3160 Porter Dr., Suite 250
Palo Alto CA 94304
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-12-01 1,000 $28.50 12,500 No 4 S Indirect See Footnote
Common Stock Disposition 2023-12-01 1,500 $30.00 11,000 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,000 Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by Thinking Bench Capital LLC on June 6, 2023.
  2. By Thinking Bench Capital LLC.